8-K: Assure Holdings Corp. Secures Shareholder Approval for Authorized Share Increase Amidst Danam Health Merger

Assure Holdings Corp. has received shareholder approval to increase its authorized shares from 9 million to 250 million, a move intended to facilitate its merger with Danam Health and maintain its Nasdaq listing.

Summary

• Assure Holdings Corp. held a special meeting on May 14, 2024, where shareholders voted to approve an increase in the company's authorized shares of common stock.
• The proposal to increase the authorized shares from 9,000,000 to 250,000,000 was approved with 5,226,969 votes in favor, 194,592 votes against, and 5,901 abstentions.
• A total of 5,427,462 shares were present at the meeting, representing approximately 60% of the issued and outstanding common stock.
• The company intends to promptly file the amendment to its Articles of Incorporation to effect the increase.
• This increase is intended to support the company's strategy to merge with Danam Health and retain its Nasdaq listing.

Sentiment

Score: 7

Explanation: The document conveys a positive sentiment due to the successful shareholder vote and the company's progress towards the merger. However, the presence of risks and uncertainties tempers the overall optimism.

Positives

• The significant increase in authorized shares provides the company with greater flexibility for future financing and strategic initiatives.
• The strong shareholder support for the proposal indicates confidence in the company's direction and the proposed merger with Danam Health.
• The increase in authorized shares is a necessary step to complete the merger with Danam Health and maintain the Nasdaq listing.
• The company is moving quickly to file the amendment to the Articles of Incorporation.

Risks

• The success of the merger with Danam Health is not guaranteed and is subject to various risks and uncertainties.
• The company's ability to manage operating expenses and expenses related to the proposed transactions is a risk.
• There is a risk of failure or delay in obtaining required approvals from governmental or quasi-governmental entities.
• Adjustments to the exchange ratio could result in Assure and Danam stockholders owning more or less of the combined company than anticipated.
• The combined company may not be able to obtain sufficient additional capital to advance its business plan.
• There is a risk of not realizing the anticipated benefits of the proposed transactions.

Future Outlook

The company is focused on completing the merger with Danam Health and maintaining its Nasdaq listing. The increased authorized shares are intended to support these goals. The company is also working to manage operating expenses and secure necessary approvals for the merger.

Management Comments

• John Farlinger, Chief Executive Officer and Chairman of Assure, thanked stockholders for their support in increasing the number of authorized shares.
• He stated that the increase allows management to continue to execute on the strategy to merge with Danam Health and retain the Nasdaq listing.

Industry Context

The announcement comes as Assure Holdings, a provider of intraoperative neuromonitoring (IONM) and remote neurology services, seeks to expand its operations through a merger with Danam Health. This move is part of a broader trend of consolidation and strategic partnerships within the healthcare technology sector.

Comparison to Industry Standards

• Increasing authorized shares is a common practice for companies preparing for mergers or acquisitions, allowing for the issuance of new shares to facilitate the transaction.
• Other companies in the healthcare technology sector, such as NuVasive and Globus Medical, have also used similar strategies to fund growth and strategic initiatives.
• The specific increase from 9 million to 250 million shares is significant and suggests a substantial need for capital, likely related to the merger and future operations.

Stakeholder Impact

• Shareholders have approved a measure that is intended to support the company's growth and strategic direction.
• Employees may be impacted by the merger with Danam Health, with potential changes in roles and responsibilities.
• Customers may benefit from the combined company's expanded services and capabilities.
• Suppliers and creditors may be affected by the merger, with potential changes in business relationships.

Next Steps

• The company will file the amendment to the Articles of Incorporation to effect the increase in authorized shares.
• The company will continue to work towards completing the merger with Danam Health.
• The company will mail the proxy statement/prospectus to the Assure and Danam stockholders.

Key Dates

Keywords

authorized shares, shareholder approval, merger, Danam Health, Nasdaq listing, common stock, intraoperative neuromonitoring, IONM